GDF2 and pulmonary arterial hypertension: A WGS study of 1048 patients with PAH by Gräf and colleagues9 screened and found novel mutations inGDF2 (which codes for BMP9) and identifiedATP13A3,AQP1, andSOX1710 as novel gene candidates, although the specific pathogenic mechanism of these in PAH remains to be determined.